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Abstract
Telomeres may regulate human disease by at least two independent mechanisms. 1) Replicative
senescence occurs once short telomeres generate DNA damage signals that produce a barrier to
tumor progression. 2) Telomere Position Effect (TPE) can change gene expression at intermediate
telomere lengths in cultured human cells. We here report a human disease, facioscapulohumeral
muscular dystrophy (FSHD) where telomere length may well contribute to its pathogenesis. FSHD
is age-related and genetically only 25-60 kb from the end of chromosome 4q. We used a floxable
telomerase to generate isogenic clones with different telomere lengths from patients and their
unaffected siblings. DUX4, the primary candidate for FSHD pathogenesis, is upregulated >10-fold
in FSHD myoblasts-myotubes with short versus long telomeres, and its expression is inversely
proportional to telomere length. FSHD may represent a human disease in which TPE contributes
to its age-related phenotype.
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Facioscapulohumeral muscular dystrophy (FSHD1A, MIM 158900) is one of the most
prevalent myopathies, affecting approximately 1:20,000 individuals 1-4. It is genetically
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linked to a reduced number of tandemly repeated 3.3 kb D4Z4 elements present near the
telomere of chromosome 4q. Normal individuals contain up to 100 repeats while only 1-10
repeats are present in patients with FSHD 5,6. The disease has a highly variable clinical
expression of progressive atrophy and weakness of the facial, scapular and upper arm
muscles (hence the name) and has the unusual characteristic for myopathies of delayed
appearance, where symptoms often do not appear until the second/third decade or later 7.
The disease requires additional genetic markers present on both sides of the repeats (Fig.1a).
The current leading candidate mediating pathogenesis in FSHD is the DUX4 homeobox
protein in the final D4Z4 repeat 8-10. The long, but not the short, form of DUX4 is toxic
when overexpressed 11-13, though toxicity of endogenous DUX4 has not yet been
demonstrated. It has become increasingly clear that there are additional factors contributing
to the pathogenesis of FSHD. Although FSHD has traditionally been considered an
autosomal dominant disease, the prevalence of its genetic signature (a reduced number of
D4Z4 repeats on chromosome 4 in combination with the 4A161PAS haplotype) is present in
~1% of the general population 14, roughly two orders of magnitude higher than the incidence
of the disease. Moreover, DUX4-fl mRNA and protein is expressed in some unaffected
subjects without D4Z4 deletions 15. This suggests other unknown factors are important.
Telomere shortening has primarily been investigated as a tumor-suppression mechanism. It
limits the number of available divisions before some telomeres become sufficiently short to
induce a non-repairable DNA damage signal. This causes growth arrest and prevents pre-
malignant cells from continuing to accumulate the changes needed to form progressive
tumors 16. A second function of telomere shortening that has received relatively little
attention is its potential for regulation of gene expression by trapping adjacent genes in
heterochromatin known as Telomere Position Effect (TPE)17.
There is no explanation for the delayed onset of FSHD. There has been speculation about
Position Effect Variegation (PEV), the term derived from the Drosophila melanogaster
literature to describe the repression of genes by adjacent heterochromatin 18. TPE describes
the special case of PEV that occurs for genes located near telomeres. TPE, originally
described in D. melanogaster and S. cerevisiae19,20, exists in mammalian cells expressing
artificially produced reporter constructs 21-24. A single endogenous human gene located
1Mb from the end of chromosome 1p, ISG15, has been found to be regulated by telomere
length 25. Because many genes distal to ISG15 are not regulated by telomere length, it does
not conform to classical TPE in which repression extends in a continuously decreasing
fashion from the telomeres. ISG15 is involved in innate immunity, and although an
attractive candidate for contributing to an increased aging inflammatory response
(“inflammaging”), it has so many inputs driving its expression that it will be difficult to
establish that telomere shorting is an important contributor.
The presence of the FSHD locus adjacent to the end of chromosome 4q raises the possibility
that >300 kb of D4Z4 repeats function as an insulator 26,27-repressor 26 that both blocks
expression of DUX4 (repressor function) and the spreading of telomeric heterochromatin
(insulator function) in normal individuals. The loss of these activities in contracted alleles
would then permit telomere shortening to regulate the expression of internal genes. This
could explain the age-associated manifestation of symptoms, since significant shortening
might be required before genes such as DUX4 were upregulated (Fig. 1b). To answer this
question, we first obtained muscle samples from both affected FSHD patients and their
unaffected family members. We then immortalized myoblasts using a floxable telomerase
(TERT) cDNA 28, isolated individual clones, excised TERT at different times, and
examined the effects of telomere shortening on gene expression in isogenic cell lines in the
absence of confounding factors. We demonstrate that DUX4 full-length (DUX4-fl)
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expression is upregulated by telomere shortening in cells from FSHD subjects; in some
cases 100-fold between cells with long and short telomeres. The effect is progressive with
decreasing telomere length and occurs long before terminal telomere shortening would
induce replicative senescence. The targets of DUX4 expression are also upregulated as a
consequence of the TPE induced increased expression of DUX4. The effect of TPE is most
prominent with DUX4, the gene nearest the telomere. The effect of TPE is present but less
prominent compared to DUX4 with FRG2, approximately 70 kb more internal, and not
observed with FRG1, an additional 90 kb from the telomere (Fig. 1a). TPE in FSHD thus
follows the classical model of continuous heterochromatin spreading that declines with
distance from the telomere. FSHD is thus the first human disease in which classic TPE may
play a role in its age-related pathogenesis.
ONLINE METHODS
Cell culture
Human myoblasts 28 were seeded in dishes coated with 0.1% pigskin gelatin (Sigma
Aldrich) in 4:1 DMEM:Medium 199 supplemented with 15% FBS, 0.02 M HEPES, 1.4 mg/l
vitamin B12, 0.03 mg/l ZnSO4, 0.055 mg/l dexamethasone, 2.5 μg/l hepatocyte growth
factor, and 10 μg/l basic-FGF. Cultures were passaged at ~50% confluency in 2-5% oxygen.
Population doublings (PDs) were calculated as PD = ln[(final number of cells)/(initial
number of cells)]/In(2). Cell strains used in this study are described in Supplementary Table
1. GM17731 and 38/03 were from Coriell Cell Repository (Camden, NJ) and Muscle Tissue
Culture Collection (University of Munich), respectively.
For differentiation, cells seeded in growth medium were switched to differentiation medium
(2% horse serum in 4:1 Dulbecco modified Eagle medium: Medium 199) when 70-90%
confluent.
Reversible immortalization
Primary human myoblasts prematurely growth arrest in culture for unknown reasons
unrelated to telomere length (e.g., lack of an appropriate growth factor). We have shown
expression of CDK4 can bypass this premature growth arrest in myoblasts without affecting
normal cell cycle kinetics or the ability to differentiate normally 28,47. Primary cultures were
first transduced with CDK4 to maintain CD56+ myogenic cells, then with an excisable
telomerase (Lox-TERT-hygromycin). Lox-TERT-hygromycin was excised by Cre-
recombinase, by transient transfection with pOG231 48 or stable integration of retroviral
Cre. Excision of TERT-hygromycin was confirmed in clones by testing for hygromycin
sensitivity and telomerase activity.
Terminal restriction fragment (TRF) assay
TRF assays were done as described 49.
Quantitative real-time RT-PCR
Cells were lysed (RNeasy plus kit (Qiagen)) after washing with PBS, scraped (BD
Biosciences) and sheared by centrifugation through Qiashredder columns (Qiagen). Total
RNA purified according to the manufacturer’s instructions was quantified on a Nanodrop
1000 spectrophotometer (Thermo Scientific). 2 μg total RNA was reverse transcribed in 20
μl (Transcriptor first strand cDNA synthesis kit (Roche), including random hexamers and
oligo(dT)18 primers). The cDNA was diluted 1:4 in water for quantitative RT-PCR (qRT-
PCR) in triplicates (Lightcycler 480 (Roche)).
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Supplementary Table 3 lists primers and PCR conditions. Melting curves were analyzed
(SYBR green or EvaGreen assays) to exclude nonspecific amplification products. We
confirmed amplicon size at least once on agarose gels. Crossing- point (Cp) values were the
second derivative maximum. Cp values were normalized by subtracting the geometric mean
of three housekeeping genes (GAPDH, PPIA and HPRT1). All Cp values were corrected by
their PCR efficiency, determined by 1:2 or 1:4 cDNA dilution series. Cp values are on a
reversed axis where a decreased Cp indicates increased mRNA.
High throughput quantitative real-time RT-PCR
High-throughput qRT-PCR used the BioMark 96.96 Dynamic Array (Fluidigm) with
TaqMan Gene Expression Assays (Applied Biosystems). 1.25 μl of cDNA was pre-
amplified (pooled and 1:100 diluted TaqMan assay mix, final concentration 0.2X) for 14
cycles, then diluted 1:5 with 1X TE buffer. 2.5 μl of each diluted sample was mixed with
TaqMan Gene Expression Mastermix, distributed into BioMark 96.96 Dynamic Array
nanoliter reaction chambers and simultaneously injected with 2.5 μl of 10X TaqMan assay
mix. Each reaction was analyzed in triplicate.
Qualitative PCR for DUX4 splicing
Splicing of DUX4 transcripts 13,15 used Phusion Hot Start II High-Fidelity DNA Polymerase
(Fisher Scientific). Primers were 14 for and 183 rev nested with 15A for and 184 rev
(Supplementary Table 3). PCR conditions: 98°C 2 min, 25 cycles 98°C 15 s, 62°C 20 s,
72°C 1 min, final extension 72°C 10 min. 8% of this PCR reaction was used for nested PCR:
98°C 2 min, 20-30 cycles 98°C 15 s, 62°C 15 s, 72°C 50 s, final extension 72°C 10 min.
PCR products from 1-2% agarose gels were gel purified and sequenced.
Reporter assay
Myoblasts co-transfected with DUX4-promoter- or FRG2-promoter-Firefly luciferase
constructs 9,33 and an SV40-driven Renilla luciferase (Promega), using PolyJet (SignaGen)
were either harvested 48 h after transfection or after an additional 5 days in differentiation
medium. Luciferase was measured using the Dual-Luciferase Reporter Assay System
(Promega) on an Optocomp I luminometer (MGM Instruments).
Statistical analysis
Rates of DUX4 detection in qRT-PCR data were fit with a binomial mixed-effect model
using R package lme4 15,50. Fixed effects were D4Z4 locus length (contracted or normal),
telomere length (long or short), cell state (cycling or differentiated), and muscle type (biceps
or deltoid), including all interactions between these. Random effects for qRT-PCR date and
batch (each consisting of three technical replicates), days post differentiation, and subject of
origin accounted for these additional sources of variation. Each fixed effect significance was
computed using a likelihood ratio test of the full model versus with the fixed effect deleted.
Determination of the fraction of cells expressing DUX4-fl from samples containing limiting
cell numbers
A multi-level probabilistic model calculated whether increased expression of DUX4 was
from increased expression per cell or a greater fraction of cells expressing DUX4.
Differentiated cells were trypsinized, and a nuclear aliquot taken (after centrifugation, the
pellet was incubated in hypotonic solution (0.1M Na-citrate pH 7.5, 2% Triton-X-100, 0.5%
SDS, 5 min), vortexed and hemocytometer counted with trypan blue). Remaining cells were
centrifuged, washed (cold PBS), resuspended (cold PBS), and diluted to the desired
concentration of nuclei. Aliquots (50 ul PBS) were added to 50 ul 2x lysis buffer (200 mM
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Tris-HCl pH7.5, 1M LiCl, 20mM EDTA, 2% LiDS, 10 mM DTT) and frozen (−80°C).
mRNA was isolated from individual aliquots using Dynabeads mRNA Direct kit (Life
Technologies), eluted by heat and reverse transcribed (oligo(dT)18 primers, 25 ul,
Transcriptor first strand cDNA synthesis kit (Roche)). 2 ul served as template for DUX4-fl
3′ PCR 13 in triplicates. Primers 182 for and 183 rev were nested with 1A for and 184 rev.
Cycling conditions were as above, with decreased extension times (40 s first PCR, 30 s
second PCR). Amplicons were run on 2% agarose gels, gel purified and sequenced.
We used a multi-level probabilistic model that accounts for (1) variability in the number of
copies of DUX4 in any aliquot, due to variability per cell; (2) variability in the number of
copies of DUX4 per replicate given the number per aliquot, due to stochastic multinomial
sampling; and (3) variability in whether DUX4 is detected in a replicate given the number of
copies of DUX4 in the replicate, due to stochastic effects in PCR.
For (1), we use a zero-inflated Poisson (ZIP) model 38 for the number of copies of DUX4
per cell. This models a situation in which at the time of mRNA extraction, with probability β
the number of DUX4 transcripts in a cell follows a Poisson distribution with mean λ, and
zero transcripts has a probability of 1 – β. Note that a cell from the Poisson component of
this mixture may also have count zero (with probability e−λ), so the overall distribution X
for each cell is  for k > 0 and Pr(X = 0|β,λ) = (1 – β) + β · e−λ
If X follows this ZIP distribution for each cell, then the distribution for the total number Y
of DUX4 transcripts in an aliquot of n cells is given by
where  is the binomial coefficient.
For (2), if k is the number of DUX4 transcripts in a cell aliquot, which has volume 25 μl,
then the number of DUX4 transcripts ri in each of the three 2 μl replicates sampled from this
aliquot follows a multinomial distribution, with
For (3), we model the probability of detecting DUX4 in a replicate that initially has ki copies
of DUX4 by Pr(di = 1|ri = ki,γ) = 1 – (1 – γ)ki where the probability γ represents the
probability of detection when there is initially 1 copy of the transcript, and di in {0,1} is an
indicator variable for detection. To make the parameter estimates more robust to outliers we
include a 2% probability that detection will be random for any given replicate, and a 2%
probability that all three replicates from any given aliquot will take the same random value,
so
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where δij is the Kronecker delta.
With the parameters π = (β, λ, γ) specified we can compute the joint probability of
detecting DUX4 in any number of replicates for an aliquot by summing the products of the
probabilities from (1-3) over all k in (1) and all k1, k2, k3 ≤ k in (2). (For computational
efficiency we lumped together all k > 15k1/2 + 50/log(1/(1 – γ)) in (1) and approximated the
multinomial in (2) by the product of three binomial distributions for k > 1000; since the
probabilities in (3) converge for large k and are bounded away from zero, this had a
negligible effect on the log-probabilities.)
Then applying Bayes’ rule we can compute the likelihood of the parameters 51 given the
combined observed data in Supplementary Table 2. Fig. 6a and b show the log-likelihood
surfaces for β and λ when γ is fixed at 0.5. Fig. 6c and d show the marginal posterior
probability distributions for β and λ, using a uniform [0, 1] prior for β and an exponential
(scale=100) prior for λ. The estimates for β were largely insensitive to the choice of γ in the
range from 0.1 to 0.9 examined (Fig. 6e), whereas the estimates of λ varied inversely with γ
(Fig. 6f).
RESULTS
Generating clonal cell lines with long and short telomeres
Primary cultures are heterogeneous, both in terms of cell types and telomere lengths within a
particular cell type. In order to experimentally isolate the effects of telomere length from
other confounding factors, we first isolated clones and then produced isogenic subclones
with different telomere lengths using a floxable TERT. Cells were obtained from two family
cohorts (01 and 15) with affected and unaffected family members 28,29. One additional
FSHD strain (GM17731) and one myopathy control (Merosin-deficient congenital muscular
dystrophy, MDC1A, 38/03) were included. Multiple isogenic subclones were derived from
12 lines (e.g., deltoid and biceps from one individual equals two lines) described in
Supplementary Table 1: seven lines from FSHD subjects, four from matched unaffected
sibling controls, and one from the MDC1A control myopathy. Importantly, we controlled for
family effects 29 by comparing FSHD lines to lines from unaffected siblings (Supplementary
Table 1: e.g. lines 15Vbic and 15Vdel are derived from biceps and deltoid of the unaffected
sister of FSHD subjects 15A and 15B, both of which have contracted D4Z4 alleles). Primary
muscle cultures transduced with CDK4 [to circumvent growth arrest due to inadequate
culture conditions 30 (Fig. 1c), enabling the isolation of myogenic clones] were reversibly
immortalized with a floxable TERT 28. Excision of TERT by Cre-recombinase one week
after TERT introduction yielded subclones with slightly elongated telomeres and extended
lifespan (Fig. 1d: compare 15Abic subclone 1 (orange line) with the parental CDK4 clone
(black line); see Supplementary Fig. 1 for other clones). In vitro propagation produced
shortened telomeres (e.g., subclone 1 of 15Abic in Fig. 1e and other clones in
Supplementary Fig. 1). An isogenic subclone with long telomeres was generated by excising
TERT ~60 population doublings (PDs) after its introduction (e.g., subclone 2 in Fig. 1d and
e). All clones and subclones were tested for efficient fusion into multinucleated myotubes
when switched to differentiation medium. Clones with short telomeres were used before the
end of their logarithmic growth phase, well before the onset of replicative senescence.
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DUX4 and FRG2 are induced in FSHD with short telomeres
Several genes have been reported as dysregulated in FSHD, including the current primary
candidate DUX4 8,13, FRG2, FRG1, and SLC25A4 31,32. We investigated the effects of
telomere length on transcription of these genes by measuring their mRNA levels using qRT-
PCR. Fig. 2 shows representative results for the three genes closest to the 4q telomere
(DUX4, FRG2 and FRG1, see Fig. 1a for genomic locations) in isogenic subclones with
long (light colors) or short telomeres (dark colors), derived from two brothers with a
shortened FSHD locus (15A and 15B, blue bars) and their unaffected sister without a D4Z4
contraction (15V, red bars). Data from independent repetitions are combined in
Supplementary Fig. 2a and b. Subclones from unaffected 15V did not express detectable
DUX4 under any condition, as expected from their nonpermissive genotype (4qB/4qB and
missing the poly(A) signal that stabilizes DUX4 transcripts) 15. We found that most cycling
FSHD subclones with long telomeres had DUX4 levels 5 crossing-point (Cp) values (~30x)
above the qRT-PCR detection limit that increased 4-1000x upon telomere shortening.
Differentiation increased DUX4 levels as reported 15. Short telomeres augmented this
increase. 15Abic, 15Bbic and 15Bdel showed ~8 Cp difference (~250x increased
expression) between short and long telomeres. The 15Adel subclone exhibited a smaller
increase (3-4 Cp: ~10x-20x). DUX4 detection rates were significantly higher in samples
with shortened versus normal D4Z4 loci (p = 1.2×10-4), in samples with short versus long
telomeres (p = 9.9×10−11), and in differentiated versus cycling cells (p = 1.1×10−3,
likelihood ratio test for binomial mixed-effect models). FRG2 was similarly regulated by
both differentiation and telomere length in FSHD cells. Although expressed by cells without
D4Z4 contractions (15Vbic and 15Vdel), these controls showed no induction by
differentiation or telomere shortening. FRG1 levels were constant under all conditions
tested, as were other more centromeric genes at 4q (LRP2BP, PDLIM3 and SLC25A4, data
not shown). We confirmed that all subclones, whether FSHD or controls, long or short
telomeres, had similar expression profiles of several skeletal muscle differentiation markers
(Supplementary Fig. 3a).
We confirmed the generality of these results in six additional subclones from three FSHD
lines and five additional subclones from three control lines (Supplementary Fig. 2c-f). We
found increased expression of both DUX4 and FRG2 in both subclones of FSHD line
01Adel, 1/3 subclones from FSHD line 01Abic, and the subclone from FSHD line
GM17731. We observed DUX4 in two subclones from unaffected subject 01Ubic, one from
01Udel, and saw it slightly upregulated in cells with short telomeres. Importantly, we did not
detect DUX4 in cells from an unrelated myopathy, and found FRG2 levels were similar to
cells from healthy donors, and marginally regulated by telomere length (Supplementary Fig.
2c).
To summarize, we demonstrated that the two genes closest to the telomere at chromosome
4q, but not more centromeric genes, are regulated by telomere length, specifically in cells
with contracted D4Z4 repeats.
DUX4 expression is inversely proportional to telomere length
Fig. 3a shows the general outline of our approach to generate samples from an FSHD clone
(01Adel) with a wide range of telomere lengths. The corresponding growth curves are
depicted in Fig. 3b. We treated the Lox-TERT expressing clone (red line) with Cre-
recombinase at various times to produce subclones of different telomere lengths and time in
culture. We obtained subclone 1 with ~20 kb telomeres (point A in Fig. 3b) by excising
Lox-TERT after 37 PDs (Fig. 3a). We then cultured these cells and harvested samples at
multiple time points (B-G in Fig. 3b). We excised TERT after 180 PDs to yield subclone 2
which had ~24 kb telomeres at the time of analysis at PD 216 (Fig. 3a and b). We analyzed
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telomere length, and DUX4 and FRG2 mRNA levels for all samples. We found a linear
correlation between telomere length and DUX4 Cp values for cycling and differentiating
myoblasts, with correlation coefficients of 0.93-0.96 (Fig. 3c). We showed that the
continuous increase in DUX4 expression in subclone 1 is not simply due to accumulating
PDs since subclone 2 with ~24 kb telomeres exhibited the lowest level of DUX4 at the same
PD when subclone 1 had the highest (PD 216, samples A and H in Fig. 3b and c). We also
found that FRG2 expression inversely correlated with telomere length, although the
correlation was weaker (correlation coefficient 0.7 for differentiating cells, Supplementary
Fig. 4).
DUX4 and FRG2 regulation by telomere length is direct
Transiently transfected reporter constructs containing the DUX4 or FRG2 promoter fused to
luciferase 9,33 should respond if DUX4 and FRG2 upregulation in cells with short telomeres
were regulated in trans rather than directly by the adjacent telomere. However, we found
that both promoter constructs were equally active in cells with long or short telomeres (Fig.
4). We demonstrated that these reporter constructs could effectively respond to trans-acting
regulatory factors, as they were induced 10-fold with differentiation as at their native
telomeric position (Fig. 4).
DUX4 induction by telomere shortening induces DUX4 targets
DUX4-fl has two N-terminal homeodomains 34 that mediate sequence specific DNA binding
and a C-terminal transactivation domain 35. A cryptic splice site can remove the C-terminal
domain producing DUX4-s 13 with dominant negative activity following overexpression 36.
DUX4-fl, but not DUX4-s, is thought to cause or at least contribute to FSHD 13. The DUX4
data in Figs. 2 and 3 did not distinguish between DUX4 splice variants. The level of DUX4
is far too low to observe by Northern analysis, requiring ~50 cycles of nested RT-PCR to
detect. We consistently detected DUX4-fl in our clonal lines using RT-PCR (Fig. 5a). We
barely detected DUX4-s (01Adel is shown as representative in Fig. 5a). In agreement with
qRT-PCR, we observed stronger signals in samples from cells with short telomeres
compared to cells with long telomeres. We verified all PCR products as chromosome 4q
DUX4 transcripts by sequencing.
DUX4 activated its target genes in these cells. We observed increased transcription from
two targets (ZSCAN4 and KHDC1) 36 (the samples in Fig. 2 are shown in Fig. 5b, and eight
additional targets are shown in Supplementary Fig. 5a). Overall, we showed that DUX4
target gene expression correlated with DUX4 expression. They were expressed at low levels
in cycling cells, with a trend of being higher in both FSHD versus unaffected, and FSHD
with short versus long telomeres. We found that DUX4 target genes were slightly
upregulated with differentiation in unaffected clones compared to FSHD clones with long
telomeres (change in Cp: ~5, ~30x), and dramatically more in FSHD clones with short
telomeres (change in Cp: ~11, ~2,000x). Plotting Cp values of each target gene as a function
of DUX4 Cp gave linear correlations with R2 values of 0.79 – 0.89 (Supplementary Fig. 5b).
In summary, we demonstrated that telomere shortening led to increased expression and
transcriptional activity of DUX4-fl and its potential contribution to FSHD pathology.
Telomere shortening increases the fraction of DUX4-fl cells
The data of Fig.3 did not indicate whether telomere shortening increased the DUX4 levels
per expressing cell or the fraction of expressing cells. The number of DUX4-fl-expressing
nuclei in differentiating FSHD myoblasts is extremely low (1 in 1,000 to 2,000) by antibody
staining 13,15. The fraction of nuclei expressing DUX4-fl can be determined by what
amounts to a fluctuation analysis using limiting numbers of nuclei37. We generated cDNA
from multiple aliquots of 30 – 30,000 nuclei with long or short telomeres from an 01Adel
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subclone. Three PCR reactions from each aliquot were scored as either positive or negative.
Agarose gel images are shown in Supplementary Fig. 6. Zero, one, two or three positives
denotes the number of positive RT-PCR reactions per triplicate for a given aliquot in
Supplementary Table 2. We modeled the number of DUX4 transcripts per cell with a zero-
inflated Poisson distribution 38, embedded in a multi-level model that also accounts for
stochastic subsampling from aliquots, and stochastic RT-PCR detection. We found that the
estimated fraction of cells expressing DUX4 was ~10-fold higher for short than for long
telomeres (~1 in 200 versus ~1 in 2,000), whereas the estimated average transcript number
for those cells that do express DUX4 remained roughly the same (Fig. 6). We conclude that
TPE thus behaved like an on/off switch where increasing fractions of cells expressed DUX4-
fl as telomeres shortened.
DISCUSSION
FSHD is a complex age-related disease in which the molecular pathogenesis is poorly
understood. We demonstrated that DUX4-fl, the primary known candidate for producing
muscle toxicity, is regulated by telomere length in cultured myoblasts. FSHD is thus the first
human disease in which classic TPE could contribute to the age-related phenotype.
Significant telomere shortening occurs in myoblasts between neonates and adulthood 39. Our
data showing that DUX4 expression progressively increased as telomeres shortened does not
require FSHD telomeres to be shorter than those from normal individuals. However, the
pathological foci of degeneration and regeneration that are observed in FSHD suggest that
satellite cell proliferation with an accompanying telomere shortening might be occurring. An
attractive possibility is that myoblast proliferation produces telomere shortening, which
increases DUX4-fl expression and increased toxicity in a positive feedback loop that
contributes to disease progression.
A central issue for determining the in vivo relevance of these in vitro results will be to
determine the contribution of telomere length to the variable penetrance of FSHD that is
frequently observed. There are a variety of theoretical and technical issues that need to be
resolved before this data can be obtained. Average telomere length is highly variable in
humans, and the average length is a complex sum of different lengths on different
chromosome ends and different lengths on homologous paternally and maternally inherited
chromosomes 40-42. Much of the variability in the magnitude of TPE we have observed in
different lines could be explained by differences in telomere length of the specific
chromosome 4q containing the contracted allele. Differences in the inherited telomere length
of the contracted 4q allele could also contribute to the large variation in penetrance observed
in FSHD.
It remains to be determined how closely the relative telomere length of the contracted 4q
allele compares to average telomere length in myoblasts versus a more accessible cell
population such as circulating lymphocytes. Our data indicates the importance of pursuing
this information. Once the average telomere length is determined, in situ hybridization
techniques using probes to D4Z4 repeats, telomeric repeats and subtelomeric regions of 4q
and 10q should be able to quantify the relative signal intensity of the contracted 4q
chromosome compared to the total telomeric signal from all chromosome ends, and thus
whether the contracted allele is relatively long or short. If this explains a significant part of
the variance then it would have important clinical implications for counseling patients and
their family members.
Yeast TPE only extends a few kb into the subtelomeric regions 19,43, and it was unknown
how far TPE could extend in mammals. This study demonstrates that human TPE can
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influence gene expression at least 80 kb from the start of the telomeric repeats. This is a
minimal value, and will probably vary greatly between different chromosome ends
depending on what repressors-insulators-propagators are present.
Previous studies have shown a reduction in repressive chromatin marks and CpG
methylation in the subtelomeric region of FSHD compared to normal subjects 44. This is
consistent with the evolutionarily conserved role of cytidine methylation as a mechanism for
recognizing and silencing repetitive sequences 45. The presence of >10 repeats could induce
these subtelomeric modifications and prevent telomeric shortening from influencing gene
expression in this region. The reduction in the number of D4Z4 repeats to <11 in FSHD
could remove many of these modifications and make the region permissive for TPE.
Differences in epigenetic modifications could also explain differences in the magnitude of
TPE we observed in different subclones from the same patient.
The genetic signature for FSHD shown in Fig.1a has recently been shown to exist in 1% of
the general population, two orders of magnitude more than the prevalence of the disease 14.
This establishes that additional unknown factors contribute to this myopathy. Whether there
are few or many remains to be determined. Our observations show that telomere length may
be at least one of the contributing factors in this complex disease.
The increase in DUX4 expression when myoblasts differentiate that we and others have
observed remains unexplained. DUX4 might be a developmental factor regulating the size of
fetal muscles in the primate face and upper arms 13. These very small primary fetal
myofibers form the template for the adult musculature. Causing some of them to die might
be a normal part of human development that modulates the size of particular adult muscles.
The expression of DUX4 in some unaffected biopsies 15 and during differentiation of
normal cell cultures by us and others 15,46 would reflect a low level expression of this
normal developmental program (since expression in one nucleus of a fiber containing only
3-4 nuclei could easily cause death of the entire fiber, rather than the complex focal
degeneration seen in adult highly multinucleate muscle). The reduction in primary fibers
would then lead to a reduction in the number of adult myofibers. This minor level of
expression in normal cells would then be transformed into a major increase in FSHD as a
result of the contractions and thus reduction of the repressor-insulator function of the D4Z4
repeats.
In conclusion, we demonstrated using isogenic clones with different telomere lengths that
the expression of the toxic homeodomain protein DUX4-fl is inversely regulated by
telomere length. We compared affected and unaffected siblings from two families (as well
as additional samples), eliminating the family effects that can confound studies of FSHD 29.
FSHD appears to be the first example of a human disease in which classic TPE is able to
affect the molecular pathogenesis, as judged by its effects in cultured cells. Future studies
will need to extend these observations in vivo. Variations in telomere length may contribute
to the variable penetrance of this complex disease, and may prove valuable in counseling of
FSHD patients and their families.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Telomere position effect and FSHD.
(a) Schematic depiction of chromosome 4q. The normal D4Z4 repeat array consists of ~100
units, each 3.3 kb in length. Borderline FSHD1A patients carry <11 repeats, and <8 is
considered diagnostic. Each D4Z4 (blue triangles) encodes a DUX4 homeobox protein.
Only the A-haplotype (not B or C), which includes a polyA signal (PAS) for the most
telomeric DUX4, is associated with FSHD. Several simple sequence length polymorphisms
(SSLP) are permissive for FSHD. Distances betweenD4Z4 repeats and the promoters of
FRG1 and FRG2 are shown for contracted versus normal D4Z4 numbers. (b) We
hypothesize transcription is promoted by both short D4Z4 repeat numbers and telomere
shortening. (c) Experimental design for the derivation of isogenic myogenic subclonal cell
lines with long and short telomeres. (d) Growth curves of a clonal cell line from patient
15Abic (family 15, FSHD patient A, biceps) and the derivation of different subclones. Code:
CDK4 only (black squares), after introducing TERT (red triangles), early TERT excision
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(orange line with black circles), late TERT excision (dark blue circles). Solid lines represent
PDs during cloning when no analysis was possible. (e) Telomere restriction fragment
analysis gel showing telomere lengths of subclone 2 at PD 137 and subclone 1 at PDs 80,
114, 115, and 131.
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Figure 2.
DUX4, FRG2 and FRG1 expression in cells with short and long telomeres.
qRT-PCR was performed on subclones from two muscles (biceps and deltoid) of two FSHD
siblings (A and B) from family 15 (represented in blue: 15Abic, 15Adel, 15Bbic, 15Bdel)
and subclones from the same two muscles from their sibling (V, in red: 15Vbic, 15Vdel)
who had normal numbers of D4Z4 repeats, all with long (light colors) and short (dark
colors) telomeres. Each cell line was analyzed under growth conditions (“Cycling”, left
panel), and after 4 and 7 days in differentiation medium (“Differentiating”, right panel: first
bar of each cell line represents day 4,second bar represents day 7 in differentiation medium).
Samples in which the Cp values were equal to or more than a water-only control were
designated as “0”, to indicate that they had been analyzed and under these RT-PCR
conditions there were no detectable transcripts. FRG2 RT-PCR was optimized to
specifically detect transcripts from chromosome 4q (Supplementary Fig.3b). Shown are the
mean Cp values and standard deviation (error bars) of 3 technical replicates of a
representative experiment; each subclone has been independently analyzed 2-5 times and all
values are shown in Supplementary Fig. 2a and b. The Y-axis is plotted as decreasing values
so that an increase in mRNA appears as a taller bar. Each Cp value represents a doubling of
the input, so the difference between (for example) 15 and 20 represents a 25=32-fold
difference.
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Figure 3.
Linear correlation of DUX4 expression and telomere length.
(a) Generating isogenic subclones with various telomere lengths. (b) Growth curves for
01Adel (family 01, affected patient A, deltoid) and subclones. CDK4 only (black squares),
after introducing TERT (red triangles), early excision of TERT (orange line with black
circles), late excision of TERT (dark blue circles). Solid lines represent PDs during cloning
and expansion when no analysis was possible. Subclone 1 analyzed at PDs 80 (A), 100 (B),
146 (C), 172 (D), 196 (E), 206 (F), and 216 (G), with mean telomere lengths of 20.3, 19.8,
12.8, 11.1, 9.1, 8.8, and 7.3 kb. Subclone 2 analyzed at PD216 (H, mean telomere length
24.0 kb). (c) DUX4 Cp values versus telomere length for subclone 1 (A-G) and subclone 2
(H) of 01Adel at the PDs of Figure 3b. DUX4 for cells differentiating for 7 days (yellow
triangles), differentiating for 4 days (red squares), and undifferentiated cycling myoblasts
(light blue triangles). Correlation coefficients R2 were calculated with Excel.
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Figure 4.
Trans-acting factors do not change with telomere length.
DUX4 and FRG2 promoter constructs were transiently transfected into 15Bdel FSHD cells
with long and short telomeres. Relative luciferase activity of cell lysates show a change with
differentiation but not telomere length. +/− SD of triplicate measurements of two
independent experiments.
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Figure 5.
Functional DUX4-fl is upregulated in cells with short telomeres.
(a) Agarose gel image after RT-PCR for DUX4 splice variants in 01Adel with short or long
telomeres after 7 days in differentiation medium. The identity of the bands indicated by
arrows has been confirmed by sequencing. (b) qRT-PCR for DUX4 targets ZSCAN4 and
KHDC1 in subclones of cohort 15 with long and short telomeres (same samples as Fig. 2).
+/− SD of three technical replicates.
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Figure 6.
Estimating the fraction of cells expressing DUX4, and counts per cell that do express
DUX4.
(a) and (b) show the log-likelihood surfaces (base 2) of parameters β and λ for a zero-
inflated Poisson (ZIP) model, for long and short telomeres respectively, with γ (probability
of detecting one transcript per reaction) fixed at 0.5.
A magenta symbol (crossed circle) indicates the maximum likelihood values of λ and β.
Black contours are spaced 10 units apart, and cyan contours 1 unit apart. (The computations
omit certain combinatorial factors that are independent of the parameters, so these log-
likelihoods are defined up to an additive constant). Note that each line of slope −1 in the
(log10(β),log10(λ))-plane corresponds to the ZIP models with fixed product βλ, which
represents the mean number of DUX4 transcripts per cell when including both the Poisson
and zero subpopulations. (c) and (d) show the marginal posterior probability densities for β
and λ, respectively, with γ fixed at 0.5. Solid lines represent densities for long telomeres
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and dashed lines for short telomeres. The densities are well-separated for β (c) but have
substantial overlap for λ (d), suggesting a difference in the fraction of cells expressing
DUX4 rather than a difference in the amount of DUX4 per cell that does express DUX4. (e)
and (f) show that the same holds for other values of γ in the range from 0.1 to 0.9, although
the estimated value of λ increases as γ decreases
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